SPOCCS I and SPOCCS II
Our original work in China was a cross-sectional comparative trial that, for the first time, directly measured sensitivity and specificity of […]
Our original work in China was a cross-sectional comparative trial that, for the first time, directly measured sensitivity and specificity of […]
A population-based study of women, aged 16 to 54 years, was conducted in 3 rural ( Xinjiang , Shanxi, and
1. Int J Gynecol Cancer. 1999 Sep;9(5):411-417. doi: 10.1046/j.1525-1438.1999.99055.x. Prevalence of cervical cancer and feasibility of screening in rural China:
SHENCCAST I (The Shenzhen cervical cancer screening program I) was initiated as a collaborative effort between the provincial government of
SHENZHEN CERVICAL CANCER SCREENING PROGRAM – II Between April, 2009 and April, 2010, a multi-site, a 10,000 women population-based cross-sectional
Shenzhen Cervical Cancer Screening Trial III Using the residual stored DNA from the Cervista High Risk HPV assay used in
SHENCCAST II 1. Am J Clin Pathol. 2011 May;135(5):790-5. doi: 10.1309/AJCPKA6ATAPBZ6JQ. A population-based clinical trial comparing endocervical high-risk HPV testing
1. Am J Clin Pathol. 2024 Jun 3;161(6):535-542. doi: 10.1093/ajcp/aqad181. AmpFire HPV and ScreenFire RS HPV validation trial. Hou J(1)(2)(3),
1. J Health Care Mark. 1993 Fall;13(3):60-5. Patient callback program: a quality improvement, customer service, and marketing tool. Gombeski WR
1. Infect Agent Cancer. 2024 Nov 29;19(1):59. doi: 10.1186/s13027-024-00622-2. Analytic performance of ScreenFire HPV RS assay Zebra BioDome format and
1. BMC Womens Health. 2023 Dec 1;23(1):641. doi: 10.1186/s12905-023-02733-1 Application an internet facilitation in a community-based cervical cancer screening project.
1. Front Public Health. 2022 Nov 10;10:1010066. doi: 10.3389/fpubh.2022.1010066. eCollection 2022. Comparison of cycle threshold values of the Cobas HPV
CHICAPS (Chinese Cervical Cancer Prevention Study) Over the past several years the focus of cervical cancer screening programs designed for
With great progress in HPV assay development over the past 5-7 years, and especially PCR based assays, BGI Shenzhen (the
The Peru Cervical Cancer Prevention Study PERCAPS was a 2 Phase pilot project funded through the Merck Investigator Initiated Studies
MEXICAN CERVICAL CANCER SCREENING STUDY Our work in Mexico initially involved the “The Mexican cervical cancer screening study” (MECCS I)
MEXICAN CERVICAL CANCER SCREENING STUDY II This project took place in the State of Michoacán Mexico. Enrollment was conduced from
Over the past few years one of the new imaging technologies we have been exploring is Optical Coherence Tomography an